{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:45:55Z","timestamp":1746333955458},"reference-count":19,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/ol.2016.4635","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T09:12:57Z","timestamp":1464253977000},"page":"611-614","source":"Crossref","is-referenced-by-count":5,"title":["Long-term remission of subcutaneous panniculitis-like T-cell lymphoma with central nervous system involvement: A case report"],"prefix":"10.3892","volume":"12","author":[{"given":"YAJUAN","family":"QIU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANDAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINGZHI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"key20180108111627_b1-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.20502","article-title":"Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: A systematic analysis of 156 patients reported in the literature","volume":"101","author":"Go","year":"2004","journal-title":"Cancer"},{"key":"key20180108111627_b2-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: Definition, classification and prognostic factors: An EORTC cutaneous lymphoma group study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"key20180108111627_b3-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5858\/133.2.303","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas","volume":"133","author":"Parveen","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108111627_b4-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"key20180108111627_b5-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C","article-title":"Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases","volume":"49","author":"MacKintosh","year":"1982","journal-title":"Cancer"},{"key":"key20180108111627_b6-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-2004-861534","article-title":"Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: A review of the literature","volume":"24","author":"Colocci","year":"2004","journal-title":"Semin Neurol"},{"key":"key20180108111627_b7-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"key20180108111627_b8-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","article-title":"ISCL and the EORTC: TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: A proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC)","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"key20180108111627_b9-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2008.16.8021","article-title":"Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: A 20-year follow-up analysis of SWOG 8516 - the Southwest Oncology Group","volume":"27","author":"Bernstein","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180108111627_b10-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0959-8049(00)00171-4","article-title":"Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis","volume":"36","author":"Hollender","year":"2000","journal-title":"Eur J Cancer"},{"key":"key20180108111627_b11-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1182\/blood-2013-06-453084","article-title":"How I treat CNS lymphomas","volume":"122","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"key20180108111627_b12-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/annonc\/mdv002","article-title":"Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma - a long-term follow-up study","volume":"26","author":"Kasenda","year":"2015","journal-title":"Ann Oncol"},{"key":"key20180108111627_b13-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2014-10-604561","article-title":"R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma","volume":"125","author":"Omuro","year":"2015","journal-title":"Blood"},{"key":"key20180108111627_b14-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cncr.29023","article-title":"Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma","volume":"121","author":"Chen","year":"2015","journal-title":"Cancer"},{"key":"key20180108111627_b15-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.7314\/APJCP.2014.15.11.4733","article-title":"Fotemustine, teniposide and dexamethasone in treating patients with CNS lymphoma","volume":"15","author":"Wu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108111627_b16-ol-0-0-4635","first-page":"463","article-title":"Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity","volume":"4","author":"Vassal","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"Suppl","key":"key20180108111627_b17-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1007\/BF00684876","article-title":"Teniposide: Overview of its therapeutic potential in adult cancers","volume":"34","author":"Muggia","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180108111627_b18-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","article-title":"Glucocorticoid use in acute lymphoblastic leukaemia","volume":"11","author":"Inaba","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20180108111627_b19-ol-0-0-4635","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12185-013-1458-x","article-title":"Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: Are there any changes in the rituximab era?","volume":"98","author":"Deng","year":"2013","journal-title":"Int J Hematol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4635\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T16:34:26Z","timestamp":1656606866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,26]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/ol.2016.4635"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4635","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}